“Leganze®”: New-Age Cosmetic Products
Leganze® contains the patented ingredient Lactoactive®, which is a refined processing of colostrum combined with hyaluronic acid.
Currently, there is a wide range of anti-age cosmetic products under the last phase of development and planned to be ready for marked 2017. We plan to commercialize these products and bring them to stores across the US.
Lactoactive®:
Lactoactive® nanoparticles have shown significant promise in combating inflammation-related diseases. The particles also have an immuno-stimulatory effect.
The active substances of Bovine Colostrum in Lactoactive® are extracted and refined into particles that are so small that they penetrate the skin and, as confirmed in tests, that human cells multiply successfully when Vilact® is used.
The researchers also showed that the cream retains its effect sufficiently after application for therapeutic effect. The use of nanoparticles in pharmaceutical companies that are seeking regulatory approval for Nano-reformulations of existing medicines, are relying on safety data produced during clinical studies of the earlier, pre-reformulation version of the existing medicine.
Our research and development pipeline:
Our pipeline currently includes three lead therapeutic files and programs – Topical, Systemic and Cosmetic.
There are multiple opportunities for pharmaceutical innovation with this patent. We are conducting research studies to pursue these opportunities further, with the intent of developing marketable product and service offerings.
The Latest Breakthrough in Cosmeceutical Therapies
We are making waves in the skin care industry with our innovative Lactoactive®-based products and treatments. Using the therapeutic proteins found in this compound, we are able to regenerate skin cells and fight ageing at its core.